| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 04/29/2010 | WO2009158698A3 Targeted delivery of imaging probes for in vivo cellular imaging |
| 04/29/2010 | US20100106026 Optical imaging of induced signals in vivo under ambient light conditions |
| 04/29/2010 | US20100104514 Nanoparticle clusters and methods for forming same |
| 04/29/2010 | US20100104513 Method and system for dye assessment |
| 04/29/2010 | US20100104512 Dendritic Chelated Compounds, Methods for Making the Same and Pharmaceutical Compositions Containing the Same |
| 04/29/2010 | US20100104506 Nanoparticle-Coated Medical Devices And Formulations For Treating Vascular Disease |
| 04/29/2010 | US20100104502 Compositions and methods for detecting and treating endothelial dysfunction |
| 04/29/2010 | US20100104501 Prss23 as a biomarker, therapeutic and diagnostic target |
| 04/29/2010 | CA2740947A1 Animal model for evaluating vasomotor response in vivo |
| 04/28/2010 | EP2178862A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 04/28/2010 | EP2178860A1 Chelators, paramagnetic chelates thereof and their use as contrast agents in magnetic resonance imaging (mri) |
| 04/28/2010 | EP2178817A1 A microsphere comprising an organic lanthanide metal complex |
| 04/28/2010 | EP2178568A2 Contrast agents |
| 04/28/2010 | EP1546362B1 Apolipoprotein e stable folding intermediate and methods of use thereof |
| 04/28/2010 | EP1359872B1 Vertebroplasty injection device |
| 04/28/2010 | CN1774205B Method for spatially resolved determination of magnetic particle distribution in an area of examination |
| 04/28/2010 | CN101698107A Sterilizing medical ultrasonic coupling agent |
| 04/28/2010 | CN101698106A D-glucosamine-modified iron oxide nanoparticles and preparation method of lyophilized powder thereof |
| 04/28/2010 | CN101698105A Gastrointestinal tract contrast medium |
| 04/27/2010 | US7705198 screening agent for ability to modulate energy expenditure by administering agent to transgenic mouse whose genome comprises homozygous disruption of endogenous KSR-2 gene, where no KSR-2 protein is expressed and said mouse exhibits a phenotype comprising increased obesity and reduced energy expenditure |
| 04/27/2010 | US7705197 Embryo development and survival |
| 04/27/2010 | US7704740 Nanofibrillar structure and applications including cell and tissue culture |
| 04/27/2010 | US7704497 Molecules with extended half-lives, compositions and uses thereof |
| 04/27/2010 | US7704488 may be coated on or incorporated within bulk materials, which may then be subsequently utilized to fabricate a radiopaque medical device; may be produced in various forms such as a dendrimer and/or incorporated as the end groups of polymeric chain |
| 04/27/2010 | CA2371816C Phthalamide-lanthanide complexes for use as luminescent markers |
| 04/27/2010 | CA2344671C Hyperpolarized noble gas extraction methods, masking methods, and associated transport containers |
| 04/22/2010 | WO2010044744A1 Novel thiophene compounds for in vivo imaging |
| 04/22/2010 | WO2010043037A1 Formulations targeting igfbp7 for diagnosis and therapy of cancer |
| 04/22/2010 | WO2010028156A8 Dual modality detection of apoptosis |
| 04/22/2010 | WO2008140624A3 Methods and compositions related to hybird nanoparticles |
| 04/22/2010 | US20100098640 Multidentate Pyrone-Derived Chelators for Medicinal Imaging and Chelation |
| 04/22/2010 | US20100098639 Compositions and Methods for Convection Enhanced Delivery of High Molecular Weight Neurotherapeutics |
| 04/22/2010 | US20100098638 RIP140 Regulation of Diabetes |
| 04/22/2010 | US20100098637 Dye-loaded nanoparticle |
| 04/22/2010 | US20100098636 Compositions for Delivery of Therapeutics and Other Materials |
| 04/22/2010 | US20100098635 Modular antigen transporter molecules (mat molecules) for modulating immune reactions, associated constructs, methods and uses |
| 04/22/2010 | US20100098626 Protein |
| 04/22/2010 | US20100098308 Pulmonary Emboli Detection with Dynamic Configuration Based on Blood Contrast Level |
| 04/22/2010 | CA2740134A1 Formulations targeting igfbp7 for diagnosis and therapy of cancer |
| 04/21/2010 | EP1471887B1 Nanoparticulate compositions having lysozyme as a surface stabilizer |
| 04/21/2010 | CN1977977B Gastro intestinal ultrasonic developer |
| 04/21/2010 | CN101697303A Preparation method of water-soluble ferroferric oxide magnetic nanoparticle with functional amidogen |
| 04/21/2010 | CN101696977A Method for determining stage of neurofibrillary degeneration |
| 04/21/2010 | CN101695576A Medical ultrasonic sterilization couplant |
| 04/21/2010 | CN101695495A Composition for treatment of external secretion disorders |
| 04/21/2010 | CN101695476A Method for preparing medical nanoparticles |
| 04/21/2010 | CN101366628B Tentaculum electric potential method for dark branchia cockchafer with lamelliform tentaculum |
| 04/20/2010 | US7700742 Antibodies to insulin-like growth factor I receptor |
| 04/20/2010 | US7700717 cyclic peptides conjugated to photoactive moieties for intraoperative diagnostic imaging, screening and real-time monitoring of photodynamic therapy efficiency |
| 04/20/2010 | US7700297 Artery- and vein-specific proteins and uses therefor |
| 04/20/2010 | US7700271 Method of diagnosis and treatment and agents useful for same |
| 04/20/2010 | US7700074 Method and system for diagnosis of neuropsychiatric disorders including chronic alcoholism |
| 04/20/2010 | CA2359573C Conjugates of colony stimulating factors for targeting and imaging infection and inflammation |
| 04/20/2010 | CA2244732C Laser opto-acoustic imaging system |
| 04/15/2010 | WO2010042512A2 Detection of atherosclerosis using indocyanine green |
| 04/15/2010 | WO2010042476A2 Methods for making particles having long spin-lattice relaxation times |
| 04/15/2010 | WO2010041742A1 Method for introducing dota |
| 04/15/2010 | WO2010040772A2 Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same |
| 04/15/2010 | WO2010040173A1 A method of delivering functional agents across the blood-brain barrier |
| 04/15/2010 | WO2009113704A3 Fluorine-containing compound and method for detecting biomolecule using the same |
| 04/15/2010 | US20100094016 Thiazoline acid derivatives |
| 04/15/2010 | US20100092396 Hyperpolarized 89-yttrium and methods relating thereto |
| 04/15/2010 | US20100092395 Acoustically delivering methods and compositons for remote treatment of a tumor |
| 04/15/2010 | US20100092394 Multimeric Particles |
| 04/15/2010 | US20100092393 Tunable hydrogel microparticles |
| 04/15/2010 | US20100092392 Pet Scanning Determination of Lymph Nodes Enriched in 124 I Labeled Antibodies for Cancer Patient Prognostication |
| 04/15/2010 | US20100092391 Imaging agents and methods of use thereof |
| 04/15/2010 | US20100092390 Methods for Making Particles Having Long Spin-Lattice Relaxation Times |
| 04/15/2010 | US20100092389 Detection of atherosclerosis using indocyanine green |
| 04/15/2010 | US20100092388 Anthracycline Derivatives |
| 04/15/2010 | US20100092385 Novel Heteroaryl Substituted Imidazo [1,2-A] Pyridine Derivatives |
| 04/15/2010 | US20100092384 Multifunctional nanoparticles and compositions and methods of use thereof |
| 04/15/2010 | CA2748995A1 Targeting construct comprising anti-polymer antibody and liposomes or microvesicles binding to the same |
| 04/14/2010 | EP2174596A1 Device for safe location and marking of a cavity and sentinel lymph nodes |
| 04/14/2010 | EP2173246A1 Macrophage-enhanced mri (memri) |
| 04/14/2010 | EP1399483B1 Antibodies to insulin-like growth factor i receptor |
| 04/14/2010 | EP1255437B1 Transgenic animal expressing a multiple mutated form of presenilin 1 |
| 04/14/2010 | CN101693114A Preparation method and application of trimanganese tetroxide nano-radiography material with target function |
| 04/13/2010 | US7696169 Inhibitors of the interaction between HMGB polypeptides and toll-like receptor 2 as anti-inflammatory agents |
| 04/13/2010 | US7695980 Chemiluminescent compounds and their use |
| 04/13/2010 | US7695903 diagnosing Alzheimer's disease by measuring abundance of low-density lipoprotein receptor related protein-1 (LRP-1), abundance of transcripts thereof, or LRP-1 receptor activity and comparing with an age-matched control |
| 04/13/2010 | US7695722 Methods for reducing GNRH-positive tumor cell replication |
| 04/13/2010 | CA2431976C Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, their production and use |
| 04/13/2010 | CA2330206C Poly(adp-ribose) polymerase gene |
| 04/13/2010 | CA2257357C Humanized antibodies with modified glycosylation |
| 04/13/2010 | CA2200868C Cdr-grafted type iii anti-cea humanized mouse monoclonal antibodies |
| 04/08/2010 | WO2010039799A1 X-ray and/or metal detectable articles and method of making the same |
| 04/08/2010 | WO2010039615A2 Papio cynocephalus toll-like receptor 3 |
| 04/08/2010 | WO2010039609A2 A version of fdg detectable by single-photon emission computed tomography |
| 04/08/2010 | WO2010037771A1 A process for the preparation of aqueous solutions of hyperpolarized molecules |
| 04/08/2010 | WO2010037231A1 Method for diagnosing cystic fibrosis |
| 04/08/2010 | WO2010018230A3 Method for detecting dysplasia |
| 04/08/2010 | US20100088773 Mutations in lama2 gene of zebrafish |
| 04/08/2010 | US20100087532 Modulation of signal transduction |
| 04/08/2010 | US20100086949 Retentate chromatography and protein chip arrays with applications in biology and medicine |
| 04/08/2010 | US20100086491 Capsule Used for Measuring Flow Information Using X-Rays and Method of Measuring Flow Information Using the Same |
| 04/08/2010 | US20100086490 Gas-filled microvesicles with targeting ligand or therapeutic agent |
| 04/08/2010 | US20100086489 Osteopenia animal model |
| 04/08/2010 | US20100086488 Hydrophilic nanoparticles with functional surface groups, production and use thereof |
| 04/08/2010 | US20100086487 Papio cynocephalus Toll-Like Receptor 3 |